Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DM1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06125834
What this trial is testing

Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Progressive Disease After TKIs or HP Therapy

Who this might be right for
Advanced Breast CancerObjective Response RateTrastuzumab Emtansine
The First Affiliated Hospital with Nanjing Medical University 36
Testing effectiveness (Phase 2)Study completedNCT01853748
What this trial is testing

T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial)

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 512
Early research (Phase 1)Study completedNCT02135159
What this trial is testing

Patients With Brain Metastases From HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 36
Not applicableStudy completedNCT02084407
What this trial is testing

Induction of Pluripotent Stem Cells From Human Fibroblasts of DM1 Patients

Who this might be right for
DM1
Institut de Myologie, France 12
Not applicableStudy completedNCT01136330
What this trial is testing

DM1 Heart Registry - DM1 Respiratory Registry

Who this might be right for
Myotonic Dystrophy
Institut de Myologie, France 914
Not applicableLooking for participantsNCT05224778
What this trial is testing

DMCRN-02-001: Assessing Pediatric Endpoints in DM1

Who this might be right for
Congenital Myotonic DystrophyCDM
Virginia Commonwealth University 50
Large-scale testing (Phase 3)Study completedNCT03523585
What this trial is testing

DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]

Who this might be right for
Breast Cancer
Daiichi Sankyo 608
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Not applicableStudy completedNCT02831504
What this trial is testing

PhenoDM1 (Myotonic Dystrophy Type 1 Natural History Study)

Who this might be right for
Myotonic Dystrophy Type 1
Newcastle-upon-Tyne Hospitals NHS Trust 213
Testing effectiveness (Phase 2)Study completedNCT00679211
What this trial is testing

Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 110
Early research (Phase 1)Study completedNCT00052000
What this trial is testing

A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 29
Testing effectiveness (Phase 2)UnknownNCT04158947
What this trial is testing

HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone

Who this might be right for
HER2-positive Breast CancerBrain Metastases
xuexin he 130
Large-scale testing (Phase 3)Active Not RecruitingNCT06316531
What this trial is testing

A Study Comparing BL-M07D1 With T-DM1 in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 274
Large-scale testing (Phase 3)Active Not RecruitingNCT06126640
What this trial is testing

A Phase III, Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy

Who this might be right for
HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
Jiangsu HengRui Medicine Co., Ltd. 1,615
Testing effectiveness (Phase 2)Study completedNCT05027269
What this trial is testing

Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients

Who this might be right for
DM1Myotonic Dystrophy 1Myotonic Dystrophy+5 more
Avidity Biosciences, Inc. 39
Early research (Phase 1)Study completedNCT01976169
What this trial is testing

Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)

Who this might be right for
Advanced Breast Cancer
University of Texas Southwestern Medical Center 29
Not applicableLooking for participantsNCT06747884
What this trial is testing

Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension

Who this might be right for
Congenital Myotonic DystrophyChildhood Myotonic DystrophyMyotonic Dystrophy
Virginia Commonwealth University 200
Not applicableLooking for participantsNCT07385443
What this trial is testing

The Spanish National Registry for Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1DM1Myotonic Dystrophy Type 1+2 more
Fundació Institut Germans Trias i Pujol 3,000
Not applicableStudy completedNCT05006924
What this trial is testing

Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy 1
Oslo University Hospital 89
Not applicableStudy completedNCT04847778
What this trial is testing

Assess the Impact of Insulclock on Glycemic Variability and Treatment Compliance in Uncontrolled DM1 Patients

Who this might be right for
Diabetes Mellitus, Type 1
Hospital General de Segovia 80
Next Page